Sponsor or institution

Clinical trials and research at Beijing Pearl Biotechnology Limited Liability Company

• 2Clinical trials
• 1Country

All recruiting trials (2)

• Vebreltinib plus platinum-based doublet chemotherapy for MET-positive non-squamous NSCLC

  This trial will test whether adding the oral drug vebreltinib to standard platinum-based doublet chemotherapy helps people with MET-positive, previously untreated locally advanced or metastatic non-squamous NSCLC.

  Recruiting Phase 3 Beijing Pearl Biotechnology Limited Liability Company · Beijing, Beijing Municipality and 1 other locations · NCT06930794

• Testing PLB1001 in lung cancer patients with a specific mutation

  This study is testing a new drug called PLB1001 to see if it helps people with a specific type of lung cancer that has a MET exon 14 mutation.

  Recruiting Phase 3 Beijing Pearl Biotechnology Limited Liability Company · Guangzhou, Guangdong · NCT05989542

Quick answers

How many clinical trials run by Beijing Pearl Biotechnology Limited Liability Company are recruiting right now?

2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in China. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 2. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →